Source link : https://www.newshealth.biz/health-news/evidence-of-durable-vision-improvement-with-gene-therapy-for-retinitis-pigmentosa/
CHICAGO — A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely vision-impaired and blind patients, a randomized clinical trial showed. After 52 weeks of follow-up, half of patients treated with MCO-010 had vision improvement of about three lines of 15 ETDRS letters, increasing to 60% at 76 weeks. Improvement […]
Author : News Health
Publish date : 2024-10-22 17:18:10
Copyright for syndicated content belongs to the linked Source.